The European Medicines Agency (EMA) announced today the launch of the new European database of suspected adverse drug reaction reports website at www.adrreports.eu. The launch of the website is a positive first step in the implementation of the EudraVigilance access policy. The information initially published on the website relates to approximately 650 medicines and active substances authorised through the centralised procedure. Within a year the EMA aims to additionally
publish suspected side-effect reports for common drug substances used in nationally-authorised medicines. Language versions of the website in all 23 community languages are set to go-live by the end of June.

Press release

Q&A